tiprankstipranks
Trending News
More News >
Allovir Inc (ALVR)
NASDAQ:ALVR
US Market

AlloVir (ALVR) Stock Statistics & Valuation Metrics

Compare
342 Followers

Total Valuation

AlloVir has a market cap or net worth of $30.20M. The enterprise value is ―.
Market Cap$30.20M
Enterprise Value

Share Statistics

AlloVir has 5,043,357 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,043,357
Owned by Insiders
Owned by Institutions

Financial Efficiency

AlloVir’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -57.76%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.50
Return on Invested Capital (ROIC)-57.76%
Return on Capital Employed (ROCE)-0.58
Revenue Per Employee0.00
Profits Per Employee-524.72K
Employee Count112
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of AlloVir is -18.97. AlloVir’s PEG ratio is -0.32.
PE Ratio-18.97
PS Ratio
PB Ratio9.81
Price to Fair Value9.84
Price to FCF-0.72
Price to Operating Cash Flow-16.42
PEG Ratio-0.32

Income Statement

In the last 12 months, AlloVir had revenue of 0.00 and earned -58.77M in profits. Earnings per share was -0.51.
Revenue0.00
Gross Profit0.00
Operating Income-65.44M
Pretax Income-58.77M
Net Income-58.77M
EBITDA-65.44M
Earnings Per Share (EPS)-0.51

Cash Flow

In the last 12 months, operating cash flow was -67.70M and capital expenditures 0.00, giving a free cash flow of -67.70M billion.
Operating Cash Flow-67.70M
Free Cash Flow-67.70M
Free Cash Flow per Share-13.42

Dividends & Yields

AlloVir pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.85
52-Week Price Change-49.67%
50-Day Moving Average9.79
200-Day Moving Average14.55
Relative Strength Index (RSI)43.86
Average Volume (3m)11.13K

Important Dates

AlloVir upcoming earnings date is Oct 31, 2024, TBA Not Confirmed.
Last Earnings DateAug 1, 2024
Next Earnings DateOct 31, 2024
Ex-Dividend Date

Financial Position

AlloVir as a current ratio of 22.63, with Debt / Equity ratio of 0.00%
Current Ratio22.63
Quick Ratio22.63
Debt to Market Cap0.00
Net Debt to EBITDA1.81
Interest Coverage Ratio0.00

Taxes

In the past 12 months, AlloVir has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

AlloVir EV to EBITDA ratio is -737.51, with an EV/FCF ratio of -712.85.
EV to Sales0.00
EV to EBITDA-737.51
EV to Free Cash Flow-712.85
EV to Operating Cash Flow-712.85

Balance Sheet

AlloVir has $118.29M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$118.29M billion.
Cash & Marketable Securities$118.29M
Total Debt$0.00
Net Cash-$118.29M
Net Cash Per Share-$23.45
Tangible Book Value Per Share$0.98

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for AlloVir is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast72.12%

Scores

Smart Score3
AI Score41
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis